Mandatory notification of trade

28 Oct 2025 08:41 CET

Moss, 28 October 2025

Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a primary insider in Gentian:

Matti Heinonen, Chief Executive Officer and primary insider in Gentian, has
purchased 5,000 shares in Gentian at NOK 54.86 per share. Mr. Heinonen owns
5,000 shares and 100,000 options after this transaction.


PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25

More information:
Access the news on Oslo Bors NewsWeb site

658078_MH_20251027_KRT1500.pdf